Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Biogazelle Develops Lab Products Beyond Industry Standards

Published: Wednesday, October 17, 2012
Last Updated: Wednesday, October 17, 2012
Bookmark and Share
New product line consists of 20000 individual real-time PCR assays.

Bio-Rad Laboratories has recently launched a new product line that was designed in conjunction with the Belgian company Biogazelle.

The new product line consists of 20000 individual real-time PCR assays, known as PrimePCR assays, all of which have been validated beyond international lab standards by Biogazelle.

The PrimePCR assays promise to save researchers time and resources to execute laboratory experiments in which the activity of particular human genes is measured.

Their use constitutes an important step to comply with recently established standards improving the quality and reliability of such experiments.

All PrimePCR assays were validated to comply with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines.

A multidisciplinary team of bio-informaticians, lab technicians and academic experts have been working on this prestigious project for more than a year. “We are delighted that our development pipeline leads to the expansion of Bio-Rad’s portfolio, which underscores the commercial viability and success of our RD strategy focusing on quantitative PCR (qPCR) and its applications,” said Jo Vandesompele, Chief Executive Officer at Biogazelle.

qPCR is a widely used laboratory method for molecular nucleic acids research and diagnostics.

Being an acknowledged global leader in the qPCR field, Biogazelle is proud to be a developer and provider of products validated beyond industry standards and common research practice.

“Biogazelle provides researchers knowledge, products, services and analysis tools to support the quality and reliability of their qPCR analyses,” said Jan Hellemans, co-founder and Chief Executive Officer at Biogazelle.

Biogazelle is committed to contribute to scientific progress, accelerating discoveries when it comes to understand diseases, discover new biomarkers, support crop improvement or other developments that make our society a better place to live in.

Biogazelle will continue its long-term collaboration with Bio-Rad for the development of similar products in the years to come. Biogazelle’s development pipeline is working at full speed.

In 2013, the human PrimePCR assays will be complemented with qPCR assays for mouse, covering nearly all protein coding genes in human and mice.

Assays targeting protein-coding genes for other genomes and assays targeting other types of genes will follow shortly.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biogazelle Attracts New Investors
UGent spin-off Biogazelle attracts new investors QBIC Arkiv Fund, Foundation Majoie and SOFI to finance growth.
Tuesday, October 07, 2014
Biogazelle Serves as Reference Laboratory for Bio-Rad's ddPCR System
Biogazelle’s and Bio-Rad’s long-term partnership extends.
Monday, September 30, 2013
VIB Inks qBase+ Group Licensing Agreement with Biogazelle
VIB to accelerate its qPCR analyses by using qbase+ as the software.
Monday, May 20, 2013
Biogazelle Appoints Kris Vanhercke as Chief Operating Officer
New appointment strengthens business development and marketing expertise of Biogazelle.
Monday, September 24, 2012
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos